Revealing Findings From A Genetic Study Of Children Affected By Duchenne Myodystrophy In Kazakhstan

Authors

  • Ainur Umurzakova Department of Neurology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
  • Dinmukhamed Ayaganov Department of Neurology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
  • Roza Nurgaliyeva Department of normal physiology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
  • Kamalzhan Nadyrov Astana Medical University
  • Sarkyt Kozhantayeva Head of the Department of Otolaryngology and Ophthalmology, Doctor of Medical Sciences
  • Gulnara Sakhipova Department of General Medicine, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
  • Aniya Seypenova Department of General Medicine, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
  • Akzhunus Mannapova Department of Neurology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
  • Azat Chinaliyev Interventional radiologist “National Research Oncology Center” Astana, Kazakhstan
  • Ainur Donayeva Department of normal physiology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan

DOI:

https://doi.org/10.3329/bjms.v24i1.78744

Keywords:

neuromuscular disorders, Duchenne myodystrophy, genetic research, mutations, sequencing.

Abstract

Duchenne muscular dystrophy is an inherited neuromuscular disorder that follows an X-linked recessive pattern of inheritance. It manifests as a severe condition characterized by progressive muscle degeneration due to mutations in the DMD gene, which is responsible for encoding the dystrophin protein.

Objective To assess clinical changes in children with Duchenne myodystrophy from the type of DMD gene mutation.

Material and methods The study involved 97 boys aged from 3 to 15 years, the average age of onset of the disease was 3.2±0.18 years. To study patients, laboratory research methods were used, such as a biochemical blood test (creatinine phosphokinase level), and a search for a genetic mutation in the DMD gene was carried out using MLPA and NGS. Clinical manifestations of this disease were assessed using functional status scales.

Results Among the children studied, MLPA revealed deletions in 56 (57.5%), large duplications in 13 (13.2%), and point mutations in 28 (29.3%). The remaining mutations were situated closer to the terminal part responsible for the linkage of the dystroglycanprotein complex within the muscle framework.

Conclusion In our investigation, we explored the correlations between primary clinical data and different mutation characteristics. Our analysis revealed a significant and reliable association between early loss of independent movement, as well as early disease onset, and mutations capable of disrupting the translational reading frame of the dystrophin protein. Given that neuromuscular diseases, including genetic disorders, represent a pressing issue in clinical neurology, these findings underscore the importance of understanding such correlations in managing these conditions.

Bangladesh Journal of Medical Science Vol. 24 No. 01 January’25 Page : 279-284

Downloads

Download data is not yet available.
Abstract
287
PDF
308

Downloads

Published

2025-01-07

How to Cite

Umurzakova, A., Ayaganov , D., Nurgaliyeva, R., Nadyrov , K., Kozhantayeva, S., Sakhipova , G., … Donayeva, A. (2025). Revealing Findings From A Genetic Study Of Children Affected By Duchenne Myodystrophy In Kazakhstan. Bangladesh Journal of Medical Science, 24(1), 279–284. https://doi.org/10.3329/bjms.v24i1.78744

Issue

Section

Original Articles